Related references
Note: Only part of the references are listed.The 11-β-Hydroxysteroid Dehydrogenase Type 1 Inhibitor INCB13739 Improves Hyperglycemia in Patients With Type 2 Diabetes Inadequately Controlled by Metformin Monotherapy
Julio Rosenstock et al.
DIABETES CARE (2010)
Discovery of a Potent, Orally Active 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibitor for Clinical Study: Identification of (S)-2-(1S,2S,4R)-Bicyclo[2.2.1]heptan-2-ylamino)-5-isopropyl-5-methylthiazol-4(5H)-one (AMG 221)
Murielle M. Veniant et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Preliminary report: pharmacologic 11 beta-hydroxysteroid dehydrogenase type 1 inhibition increases hepatic fat oxidation in vivo and expression of related genes in rats fed an obesogenic diet
Magalie Berthiaume et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2010)
The Role of Peroxisome Proliferator-Activated Receptor γ Coactivator-1 β in the Pathogenesis of Fructose-Induced Insulin Resistance
Yoshio Nagai et al.
CELL METABOLISM (2009)
11β-Hydroxysteroid Dehydrogenase Type 1 Regulates Glucocorticoid-Induced Insulin Resistance in Skeletal Muscle
Stuart A. Morgan et al.
DIABETES (2009)
Antidiabetic effects of 11β-HSD1 inhibition in a mouse model of combined diabetes, dyslipidaemia and atherosclerosis
D. J. Lloyd et al.
DIABETES OBESITY & METABOLISM (2009)
The role and regulation of 11β-hydroxysteroid dehydrogenase type 1 in the inflammatory response
Karen E. Chapman et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2009)
The glucocorticoid receptor controls hepatic dyslipidemia through Hes1
Ulrike Lemke et al.
CELL METABOLISM (2008)
11β-HSD1 inhibition improves triglyceridemia through reduced liver VLDL secretion and partitions lipids toward oxidative tissues
Magalie Berthiaume et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2007)
Glucocorticoids, metabolism and metabolic diseases
Alexandros Vegiopoulos et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2007)
ABCAI, ABCGI and SR-BI: hormonal regulation in primary rat hepatocytes and human cell lines
Marita Sporstol et al.
BMC MOLECULAR BIOLOGY (2007)
Aberrant hepatic expression of PPARγ2 stimulates hepatic lipogenesis in a mouse model of obesity, insulin resistance, dyslipidemia, and hepatic steatosis
Yuan-Li Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
11β-Hydroxysteroid dehydrogenase type 1 induction in the arcuate nucleus by high-fat feeding:: A novel constraint to hyperphagia?
Valerie S. Densmore et al.
ENDOCRINOLOGY (2006)
Diabetic dyslipidemia
Tina J. Chahil et al.
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA (2006)
Inhibition of 11β-hydroxysteroid dehydrogenase type 1 reduces food intake and weight gain but maintains energy expenditure in diet-induced obese mice
SJY Wang et al.
DIABETOLOGIA (2006)
11β-HSD1 inhibition ameliorates metabolic syndrome and prevents progression of atherosclerosis in mice
A Hermanowski-Vosatka et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Effects of short-term glucocorticoids on cardiovascular biomarkers
DJ Brotman et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Regulation of plasma triglycerides in insulin resistance and diabetes
HN Ginsberg et al.
ARCHIVES OF MEDICAL RESEARCH (2005)
Adipocyte-specific glucocorticoid inactivation protects against diet-induced obesity
EE Kershaw et al.
DIABETES (2005)
Genetic manipulation of 11 beta-hydroxysteroid dehydrogenases in mice
JM Paterson et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2005)
Novel adipose tissue-mediated resistance to diet-induced visceral obesity in 11β-hydroxysteroid dehydrogenase type 1-deficient mice
NM Morton et al.
DIABETES (2004)
Metabolic syndrome without obesity:: Hepatic overexpression of 11β-hydroxysteroid dehydrogenase type 1 in transgenic mice
JM Paterson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Liver fatty acid-binding protein is required for high rates of hepatic fatty acid oxidation but not for the action of PPAR-α in fasting mice
E Erol et al.
FASEB JOURNAL (2003)
Selective inhibition of 11β-hydroxysteroid dehydrogenase type 1 improves hepatic insulin sensitivity in hyperglycemic mice strains
P Alberts et al.
ENDOCRINOLOGY (2003)
Hepatic VLDL production in ob/ob mice is not stimulated by massive de novo lipogenesis but is less sensitive to the suppressive effects of insulin
CH Wiegman et al.
DIABETES (2003)
Complexity in the secretory pathway: The assembly and secretion of apolipoprotein B-containing lipoproteins
EA Fisher et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
JD Horton et al.
JOURNAL OF CLINICAL INVESTIGATION (2002)
A transgenic model of visceral obesity and the metabolic syndrome
H Masuzaki et al.
SCIENCE (2001)
Post-transcriptional stimulation of the assembly and secretion of triglyceride-rich apolipoprotein B lipoproteins in a mouse with selective deficiency of brown adipose tissue, obesity, and insulin resistance
P Siri et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Improved lipid and lipoprotein profile, hepatic insulin sensitivity, and glucose tolerance in 11β-hydroxysteroid dehydrogenase type 1 null mice.
NM Morton et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Tissue-specific dysregulation of cortisol metabolism in human obesity
E Rask et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2001)
Share Paper
